ARFID (avoidant/restrictive food intake disorder) does appear to have a significant genetic component, though research is still in its early stages. One study estimated the heritability of a continuous ARFID risk score at roughly 45%, which is comparable to other eating disorders like anorexia nervosa and bulimia nervosa. That means genetics likely accounts for close to half the risk, with environmental factors making up the rest.
What the Genetic Evidence Shows So Far
ARFID was only formally recognized as a diagnosis in 2013, so large-scale genetic studies are limited. No family or twin studies focused specifically on ARFID have been published yet. The most informative genetic investigation to date was conducted in a cohort of over 3,000 individuals with autism, where researchers examined DNA markers associated with ARFID risk. That study found a moderate, SNP-based heritability estimate of 0.45, meaning about 45% of variation in ARFID risk could be attributed to common genetic differences. The confidence interval was wide (13% to 76%), reflecting how early this research is, but the central estimate lines up with what’s seen in other eating disorders.
The same study identified a specific genetic marker on chromosome 5, near a gene called ZSWIM6, that reached genome-wide significance. This gene has previously been linked to intellectual disability and schizophrenia, both neurodevelopmental conditions. Several other suggestive markers turned up near genes involved in metabolism and brain development, though none of those reached the strict threshold for confirmation.
Different ARFID Presentations May Have Different Genetic Roots
ARFID isn’t one uniform condition. It shows up in three main ways: low appetite (you simply don’t feel hungry or interested in food), sensory sensitivity (certain textures, smells, or tastes trigger strong aversion), and fear-based avoidance (anxiety about choking, vomiting, or other negative consequences of eating). These presentations often overlap, but they appear to draw on different biological pathways.
When researchers broke ARFID risk into these subtypes, they found that the appetite and fear-based forms were more genetically associated with metabolic traits, while the picky or sensory-driven form showed stronger links to neurodevelopmental pathways. This suggests that inheriting a predisposition to ARFID may look different depending on which subtype runs in your family. A parent with sensory sensitivity around food may be passing along different genetic risk factors than a parent who simply never felt hungry as a child.
The Role of Taste Genetics
One well-studied genetic factor that likely contributes to ARFID’s sensory subtype involves how people perceive bitter flavors. A gene called TAS2R38 encodes a taste receptor that detects bitter compounds found naturally in vegetables like broccoli, kale, Brussels sprouts, and cabbage. Common variations in this gene determine whether you taste these foods as intensely bitter, mildly bitter, or not bitter at all.
People who carry the “supertaster” version of this gene perceive certain vegetables as far more unpleasant than others do, and they tend to eat fewer vegetables even when encouraged. In dietary intervention studies, people who couldn’t taste the bitterness increased their vegetable intake the most, while those with the strongest bitter perception actually decreased their intake. For a child who already has sensory sensitivities, inheriting a heightened bitter taste receptor could narrow their accepted foods even further, potentially contributing to the kind of restrictive eating pattern seen in ARFID.
Genetic Overlap With Autism and ADHD
ARFID frequently co-occurs with autism and ADHD, which raises the question of whether these conditions share genetic architecture. The evidence here is mixed and preliminary. Research on polygenic risk scores (which aggregate the effect of thousands of small genetic variants) has found a modest genetic link between autism and anorexia nervosa, supporting the idea of shared biology between autism and restrictive eating more broadly. However, no such shared genetic signal has been found between ADHD and eating disorders using the same method.
Because ARFID doesn’t yet have its own diagnostic code in many medical registries, it often gets lumped in with other eating disorders in large genetic databases, making it difficult to study directly. Researchers expect this will change as ARFID gains its own classification codes and larger dedicated studies become possible. For now, the high rate of co-occurrence with autism (where ARFID prevalence is markedly elevated) suggests overlapping neurodevelopmental genetics, particularly for the sensory-driven subtype.
How ARFID Brains Respond to Food
Brain imaging studies are beginning to reveal how ARFID differs neurologically from other eating disorders. When shown pictures of food, people with ARFID don’t show the hyperactive reward-center response that characterizes anorexia nervosa. In anorexia, the brain lights up intensely in reward regions when viewing high-calorie food, and the person actively suppresses that response as part of their drive for thinness. ARFID looks nothing like this.
Instead, people with the low-appetite form of ARFID show reduced activation in the hypothalamus, a brain region that regulates hunger signals. The more severe their lack of interest in food, the lower the hypothalamus response. This points to a fundamentally different biological mechanism: rather than fighting an urge to eat, people with ARFID may genuinely experience weaker hunger signals or less reward from eating. These brain patterns likely have a genetic basis, though the specific genes driving them haven’t been identified yet.
Environmental Factors Still Matter
Even with a heritability estimate around 45%, roughly half the risk for ARFID comes from non-genetic sources. ARFID commonly develops after a frightening experience with food, such as a choking episode, a bout of food poisoning, or a painful gastrointestinal event. Children who undergo medical procedures involving the mouth or throat, or who have early-life feeding difficulties due to reflux or allergies, are also at higher risk. These experiences can trigger or worsen food avoidance in someone who already carries genetic vulnerability.
The interaction between genes and environment is key. Many children experience a choking scare without developing ARFID. Many people carry the supertaster gene without restricting their diet to the point of nutritional deficiency. ARFID likely emerges when several genetic predispositions (heightened taste sensitivity, lower appetite signaling, neurodevelopmental differences) combine with environmental triggers and are reinforced over time.
How Common ARFID Actually Is
Prevalence estimates vary widely depending on how strictly ARFID is defined, but current data suggest it affects roughly 0.3% to 15.5% of children and 0.3% to 4.1% of adults. The higher-end numbers come from broader screening criteria, while the lower estimates use stricter clinical thresholds. Either way, ARFID is about as common as better-known eating disorders. It’s more prevalent in children than adults, partly because some children naturally expand their diet as they grow, and partly because ARFID in adults has been less studied.
What separates ARFID from ordinary picky eating is its consequences. A diagnosis requires that restricted eating leads to significant weight loss, nutritional deficiency, dependence on nutritional supplements, or meaningful interference with social functioning. The food avoidance in ARFID centers on sensory properties (taste, texture, smell, color), low appetite, or fear of negative consequences, never on concerns about body weight or shape. That distinction is what makes ARFID a different condition from anorexia, even when the two look superficially similar.